New stock news | Jili Technology submits second listing application to Hong Kong Stock Exchange
According to the Hong Kong Stock Exchange disclosure on December 31st, Suzhou JiYi Technology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange main board, with CITIC Securities as its exclusive sponsor.
According to the disclosure by the Hong Kong Stock Exchange on December 31st, Suzhou JiYi Technology Co., Ltd. (JiYi Technology) has submitted its application for listing on the main board of the Hong Kong Stock Exchange, with CITIC SEC as its sole sponsor. The company had previously submitted its application to the Hong Kong Stock Exchange on June 18, 2025. The prospectus shows that JiYi Technology is one of China's leading digital retail integrated operation service providers, providing services not only to brand owners but also to large chain stores and supermarkets as an e-commerce operation service provider. According to Frost & Sullivan, based on the Gross Merchandise Volume (GMV) in 2024, the company ranks second among digital retail integrated operation service providers in China, and fifth among e-commerce operation service providers in China, holding a 1.2% market share in the e-commerce operation service market in China.
Related Articles

HK Stock Market Move | Concept of SaaS Surges, Heavy Acquisition Serves as Agent's Repricing, Institutions Focus on Traditional SaaS Shift to Agent-oriented Paradigm Transition

New stock news: Yifang Biomedical (688382.SH) submits application to the Hong Kong Stock Exchange, focusing on areas such as tumor, autoimmune diseases, and metabolic diseases.

New Stock News | Wan Yi Medical Submits Application to Hong Kong Stock Exchange, Committed to Building a Platform for Physician Academic Development
HK Stock Market Move | Concept of SaaS Surges, Heavy Acquisition Serves as Agent's Repricing, Institutions Focus on Traditional SaaS Shift to Agent-oriented Paradigm Transition

New stock news: Yifang Biomedical (688382.SH) submits application to the Hong Kong Stock Exchange, focusing on areas such as tumor, autoimmune diseases, and metabolic diseases.

New Stock News | Wan Yi Medical Submits Application to Hong Kong Stock Exchange, Committed to Building a Platform for Physician Academic Development






